Skip to main content
OpenTrials

Clinical trial condition

Mantle Cell Lymphoma

Explore clinical trials studying Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.

252 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Mantle Cell Lymphoma trial results

Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735

Conditions
B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
View Trial Details
Recruiting

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

NCT06854003

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions
ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations
  • Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
  • Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
  • Napa Research Pompano Beach, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details

Related conditions